[1]
2022. Method Development And Validation Of Ubrogepant In Bulk And Pharmaceutical Dosage Form By Using Rp-Hplc. Journal of Pharmaceutical Negative Results. (Dec. 2022), 7690–7696. DOI:https://doi.org/10.47750/pnr.2022.13.S07.929.